NDC 70518-4710-1 - Metformin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4710
- Requested NDC
- 70518-4710-1
- Package NDCs from labels
- 70518-4710-1, 70518-4710-0, 70518-4710-2
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-08-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metformin Hydrochloride - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-08-11 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Proficient Rx LP | d8bd1779-d1c4-4dde-816d-ea72b37bb5cd | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Pioglitazone HCL and Metformin HCL | PIOGLITAZONE HCL AND METFORMIN HCL | Torrent Pharmaceuticals Limited | 237d8fa2-633c-4c29-84d3-f1b413610dc3 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 64f5b140-7ad8-4c07-bbfc-ae4618afa850 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Sitagliptin and Metformin Hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Sandoz Inc | a0fcdc08-0afc-4912-a126-3efea6bc8c61 | 2026-08-30 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ba0379cb-824e-4798-9ff9-99bcd1bea5cb | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Synjardy | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| alogliptin and metformin hydrochloride | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | Padagis Israel Pharmaceuticals Ltd | 14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Trijardy XR | EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 71873567-9594-452a-bb92-34a129adecac | 2026-08-24 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Smelling Salts | AMMONIA | Shenzhen Finona Information Technology Co., Ltd | 3874ec89-0f1d-87b9-e063-6394a90a300a | 2026-08-24 | Warnings | 5138Q19F1X |
| INVOKAMET | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Janssen Pharmaceuticals, Inc. | 6868666b-c25e-40d1-9d1f-306bbe9390c1 | 2026-08-24 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | ScieGen Pharmaceuticals Inc | 4e4c4ba9-65c6-4273-8f6b-2423ab521dad | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | 073cf6d9-7142-4d8b-898e-174c62a1f76f | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Actoplus Met | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | Takeda Pharmaceuticals America, Inc. | 42e49120-6f3f-11db-9fe1-0800200c9a66 | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Saxagliptin and Metformin | SAXAGLIPTIN AND METFORMIN | Mylan Pharmaceuticals Inc. | cbf8677c-cafe-48bc-8844-0cc6547886bd | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | QPharma,Inc. | 5866ca12-a28f-cbe7-e063-6294a90acc69 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Rohto Optic Glow | NAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | df9c5f7c-96e6-4b2b-b8cb-21a6a3342dff | 2026-08-20 | Warnings | 6DC9Q167V3 |
| Smelling Salts | AMMONIA INHALANT, SMELLING SALTS | Hodayfa Abu Alkian | 524e002c-f509-9395-e063-6394a90acd9e | 2026-08-20 | Warnings | 5138Q19F1X |
| Jentadueto | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | f6dd9b86-0d18-95d4-2bc7-05591bfdd597 | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Jentadueto XR | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 3d02a4d4-d312-80b4-05c4-691b8f0aa7aa | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Smelling Salts | AMMONIA INHALANT, SMELLING SALTS | Shenzhen Leadtop E-commerce Co.,Ltd. | 558e8629-6a8d-198d-e063-6294a90ac5fc | 2026-08-19 | Warnings | 5138Q19F1X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.